IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 12, Issue 8, Pages 849-855
Publisher
Informa UK Limited
Online
2016-03-21
DOI
10.1586/1744666x.2016.1168293
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology
- (2016) Rehana Akter et al. Journal of Diabetes Research
- Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
- (2015) P. Ruscitti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome
- (2015) Isabelle Koné-Paut et al. Expert Review of Clinical Immunology
- The Role of IL-1βin the Bone Loss during Rheumatic Diseases
- (2015) Piero Ruscitti et al. MEDIATORS OF INFLAMMATION
- Macrophages are essential for CTGF-mediated adult β-cell proliferation after injury
- (2015) Kimberly G. Riley et al. Molecular Metabolism
- FRI0219 Disease severity, no steroid use and type ii diabetes predict response to anakinra (kineret®) in patients with rheumatoid arthritis
- (2014) B. Missler-Karger et al. ANNALS OF THE RHEUMATIC DISEASES
- The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance
- (2014) P. C. M. van Poppel et al. DIABETES OBESITY & METABOLISM
- Caspases and inflammasomes in metabolic inflammation
- (2014) Alexander M Skeldon et al. IMMUNOLOGY AND CELL BIOLOGY
- Targeting inflammation in the treatment of type 2 diabetes: time to start
- (2014) Marc Y. Donath NATURE REVIEWS DRUG DISCOVERY
- Macrophages and islet inflammation in type 2 diabetes
- (2013) K. Eguchi et al. DIABETES OBESITY & METABOLISM
- Role of pancreaticβ-cell death and inflammation in diabetes
- (2013) W. Quan et al. DIABETES OBESITY & METABOLISM
- Macrophages control innate inflammation
- (2013) S. Akira et al. DIABETES OBESITY & METABOLISM
- Anakinra for cryopyrin-associated periodic syndrome
- (2013) Isabelle Koné-Paut et al. Expert Review of Clinical Immunology
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis
- (2013) Manathip Osiri et al. JOINT BONE SPINE
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Overview of the interleukin-1 family of ligands and receptors
- (2013) Charles A. Dinarello SEMINARS IN IMMUNOLOGY
- MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
- (2013) Sue Tsai et al. Frontiers in Immunology
- Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation
- (2012) Kosei Eguchi et al. Cell Metabolism
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial
- (2012) A. Rissanen et al. DIABETES OBESITY & METABOLISM
- Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
- (2012) K. P. Liao et al. RHEUMATOLOGY
- Managing Macrophages in Rheumatoid Arthritis by Reform or Removal
- (2012) Jun Li et al. Current Rheumatology Reports
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Edwin J. P. van Asseldonk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Role of IL-1β in type 2 diabetes
- (2011) Charles A Dinarello et al. Current Opinion in Endocrinology Diabetes and Obesity
- Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells
- (2010) Guangjie Chen ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity
- (2010) Marina K. Roell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic β-cell function
- (2010) Malek El Muayed et al. JOURNAL OF ENDOCRINOLOGY
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
- (2010) K. Schroder et al. SCIENCE
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I
- (2009) Marianne Böni-Schnetzler et al. ENDOCRINOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat
- (2009) J. A. Ehses et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Antiinflammatory Cytokine Interleukin-1 Receptor Antagonist Protects from High-Fat Diet-Induced Hyperglycemia
- (2008) Nadine S. Sauter et al. ENDOCRINOLOGY
- Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation
- (2008) Marianne Böni-Schnetzler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
- (2008) Rieke Alten et al. ARTHRITIS RESEARCH & THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now